• About
  • Subscribe
  • Advertise
  • Contact
Sunday, July 12, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Company updates & acquisitions

EssilorLuxottica makes play for eyeglass cases and packaging business

by Myles Hume
April 20, 2022
in Business, Company updates & acquisitions, International, News
Reading Time: 3 mins read
A A
Fedon’s business groups comprise eyeglass cases and optical accessories. Image Fedon Group

Fedon’s business groups comprise eyeglass cases and optical accessories. Image Fedon Group

Share on FacebookShare on Twitter

As it took 100% control of GrandVision and offloaded 177 stores this month, EssilorLuxottica announced a leadership reshuffle for the optical retail giant, including a new CEO.

In a separate deal, the Franco-Italian company also revealed its intention to enter the packaging and eyeglass cases market, with plans to acquire a 91% stake in the Italian firm Fedon.

After almost three years, EssilorLuxottica reached the final hurdle in its GrandVision takeover this month that will see it drastically increase its retail footprint by around 7,000 stores across 40 countries, and an additional 37,000 staff.

On 4 April, EssilorLuxottica, GrandVision and the Optic Retail International Group BENE, a member of MPG Austria (ORIG/MPG), completed a deal for ORIG/MPG to acquire 142 EyeWish stores in the Netherlands and 35 GrandOptical stores in Belgium.

The sale of these GrandVision stores was a key condition set out by the European Commission in March 2021, when it approved EssilorLuxottica’s GrandVision acquisition.

Ten days later, on 14 April, the company announced it had completed a statutory buy-out of GrandVision shareholders, seeing it take full control of the retailer.

The next day, EssilorLuxottica announced a major leadership overhaul of GrandVision, with Mr Stephan Borchert and Mr Willem Eelman deciding to step down from their respective roles as CEO and chief financial officer, effective 22 April.

They will be replaced by Mr Massimiliano Mutinelli as the new president of optical retail for EMEA at EssilorLuxottica and head of Amsterdam corporate offices at GrandVision, and Mr Niccolò Bencivenni as the chief financial officer. They will be supported by Mr Frederic Dauche as chief operating officer.

“I would like to express our most sincere thanks to Stephan and Willem for their strong leadership and significant contributions over the years. Today, we have a solid foundation to build on,” said Mr Francesco Milleri, CEO of EssilorLuxottica.

Play for optical accessories market

Meanwhile, in the Fedon deal on 11 April, EssilorLuxottica said it would represent a step towards its vertical integration strategy.

Fedon’s business groups comprise eyeglass cases and optical accessories including reading glasses, microfibre cloths, shopping bags and lens cleaning sprays that can be customised for individual stores.

“Thanks to cutting-edge technologies and dedicated innovations, the acquisition will allow to better fit eyewear and spectacles with the cases and packaging to ensure maximum protection and integrity of the product, for the benefit of the final consumer,” EssilorLuxottica stated.

“Furthermore, EssilorLuxottica will also leverage on the company to pursue its sustainability strategy, investing in the recyclability and circularity of the packaging materials.”

The Fedon deal may be completed by the end of June 2022.

More reading

Marco Caccini appointed GM Wholesale ANZ at EssilorLuxottica

European Commission clears EssilorLuxottica’s GrandVision takeover, 350 stores to be divested

GrandVision strikes new partnership to pilot online vision testing

Tags: AcquisitionEssilorLuxotticaFedonGrandVision

Related Posts

George & Matilda Eyecare boss Chris Beer has taken on a new role as executive chair of the network. Image: Prime Creative Media.

Chris Beer – not retiring, just changing lanes

by Rob Mitchell
July 10, 2026

Former CEO Chris Beer has a new role at George & Matilda Eyecare, but it’s not the end of his...

UNSW has achieved a top ranking. Image: UNSW.

UNSW named No. 1 in world for optometry research excellence

by Staff Writer
July 9, 2026

The UNSW School of Optometry & Vision Science has been recognised as the world's leading optometry school for research excellence,...

Doctors have a key role to play in eye health, according to the RACGP. Image: Graphic PNG Grid/stock.adobe.com.

GPs key to preventing avoidable vision loss, says RACGP

by Rob Mitchell
July 8, 2026

The Royal Australian College of GPs (RACGP) is highlighting the vital role GPs play in protecting Australians’ sight, with the July...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited